scholarly journals Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years

2020 ◽  
Vol 86 (5) ◽  
pp. 852-860 ◽  
Author(s):  
Tsung‐Ying Lee ◽  
Shihchen Kuo ◽  
Chen‐Yi Yang ◽  
Huang‐Tz Ou
Keyword(s):  
Type 1 Diabetes ◽  
Cost Effectiveness ◽  
Human Insulin ◽  
Population Based ◽  
Insulin Analogues ◽  
Acting Insulin ◽  
Long Acting

Revisiting the efficacy of long-acting insulin analogues on adults with type 1 diabetes using mixed-treatment comparisons

2011 ◽  
Vol 94 (3) ◽  
pp. 333-339 ◽  
Author(s):  
Andréia Cristina Conegero Sanches ◽  
Cassyano Januário Correr ◽  
Rafael Venson ◽  
Roberto Pontarolo
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Analogues ◽  
Acting Insulin ◽  
Mixed Treatment ◽  
Long Acting ◽  
Treatment Comparisons ◽  
Mixed Treatment Comparisons

scholarly journals Long-acting insulin analogues for type 1 diabetes: An overview of systematic reviews and meta-analysis of randomized controlled trials

PLoS ONE ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. e0194801 ◽  
Author(s):  
Fernanda O. Laranjeira ◽  
Keitty R. C. de Andrade ◽  
Ana C. M. G. Figueiredo ◽  
Everton N. Silva ◽  
Mauricio G. Pereira
Keyword(s):  
Type 1 Diabetes ◽  
Randomized Controlled Trials ◽  
Meta Analysis ◽  
Insulin Analogues ◽  
Controlled Trials ◽  
Randomized Controlled ◽  
Acting Insulin ◽  
Overview Of Systematic Reviews ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document